Single arm evaluation of romiplostim to prevent chemotherapy induced thrombocytopenia in patients with Ewing sarcoma.

• Ages: >1 year old

This is a single-arm, multi-center clinical trial to assess the efficacy of romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma receiving interval-compressed chemotherapy. Romiplostim-BT-2201: Single arm evaluation of romiplostim to prevent chemotherapy induce ...More